| Financial Year |
March 31 2023 |
| Monetary Funds |
258,281,476.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
163,228,148.16 |
| Advances to Suppliers |
11,392,642.67 |
| Other Receivables |
76,071,131.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
367,449,449.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,954,519.87 |
| Total Current Assets |
898,694,579.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
24,080,000.00 |
| Long-term Equity Investment |
85,054,995.78 |
| Investment Properties |
182,101,300.00 |
| Fixed Assetes |
1,371,193,719.07 |
| Under-construction Projects |
207,136,084.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
140,138,293.15 |
| R&D expenses |
-- |
| Goodwill |
380,961,409.98 |
| Long-Term Deferred and Prepaid Expenses |
154,898,129.46 |
| Deferred Income Tax Assets |
5,778,623.45 |
| Other Non-Current Assets |
342,909,081.87 |
| Sub-Total of Non-Current Assets |
3,159,253,218.84 |
| Total Assets |
4,057,947,798.71 |
| Short-Term Loans |
646,473,642.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
139,993,424.06 |
| Accounts Payable |
291,663,283.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
84,726,824.69 |
| Taxes Payable |
13,496,294.69 |
| Interest Payable |
-- |
| Dividend Payable |
855,413.98 |
| Other payables |
190,277,438.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
229,574,797.07 |
| Other Current Liabilities |
230,188.55 |
| Sub-Total of Current Liabilities |
1,779,367,582.03 |
| Long-term Loans |
372,684,355.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
52,396,499.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
469,088,986.66 |
| Total Liabilities |
2,248,456,568.69 |
| Paid-In Capital(Or Share Stock) |
768,692,614.00 |
| Capital Surplus |
192,688,196.82 |
| Surplus Reserve |
117,653,288.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
495,362,808.90 |
| Minority Stockholder's Interest |
44,815,671.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,764,675,558.65 |
| Owner's Equity（Stockholder's Equity） |
1,809,491,230.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,057,947,798.71 |
